GEERS A.I CyberSecurity Scoring
07/01/2026
Access Monitoring Plan
Access Monitoring Plan
No incidents recorded for GEERS in 2026.
No incidents recorded for GEERS in 2026.
No incidents recorded for GEERS in 2026.
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We advance our mission to alleviate pain and improve the quality of life for patients around the world with our innovative products and suite of integrated digital and robotic technologies leverage data, data analytics and artificial intelligence. Founded in 1927 and based in Warsaw, Zimmer Biomet has operations in more than 25 countries and sales in more than 100 countries. We maintain world-class scientific facilities and resources and collaborate with leading clinicians and researchers around the world. Awards and Recognitions • Forbes: America's Best Companies 2026 • Workhuman: Luminary Award 2025 & Innovator Award 2024 • TIME: America's Best Companies [Mid-Size] 2024 • Great Place to Work - Best Workplaces: Switzerland & Poland 2025 • Great Place to Work Certified 2025 - 2026: USA, Poland, India, Colombia, Ireland, Puerto Rico, Kingdom of Saudi Arabia, Switzerland • MedTech: Breakthrough Award Best New Technology Solution in Orthopedics 2025 • Top Employers Institute: China 2025 • VETS Indexes: 4 Star Employer 2025
Edwards Lifesciences (NYSE: EW), is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees in areas including Clinical Affairs, Quality Engineering, Research & Development, Regulatory Affairs, Sales & Marketing, corporate functions and more. Contact Us We want to hear from you and engage in meaningful discussions. However, please note that we are not equipped to provide customer, candidate, or technical support through this platform. If you require assistance from those teams, please find their contact information here: https://www.edwards.com/aboutus/contactus If you’re a patient in need of medical advice, please contact your healthcare provider directly. We reserve the right to remove any comments that are off-topic, repetitive, or include hate speech, profanity, or offensive language. Additionally, we will not engage in discussions about competitor products, off-label use of Edwards products, or unsubstantiated/misleading claims that could cause harm. All Terms and Conditions of LinkedIn apply. For the Edwards Lifesciences privacy policy, visit https://www.edwards.com/legal/privacypolicy.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers. A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 34 countries and territories. The Company's sales reached $12.7 billion in 2024, and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.
STERIS is a leading provider of infection prevention and other procedural products and services, focused primarily on healthcare, pharmaceutical and medical device Customers. MISSION WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. VISION We strive to be a GREAT COMPANY. We provide world-class products and services for our Customers, safe and rewarding work for our people, and superior returns for our Shareholders. • $5 Billion in revenue in FY24 • More than 17,000 Associates worldwide • Over 4,000 Customer-facing professionals • Listed on the New York Stock Exchange under the symbol “STE” To learn more, visit www.steris.com. Want to join the team? View and apply for open roles at careers.steris.com.
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. For more information, visit www.bostonscientific.com and connect with us on X, Instagram, and Facebook. At Boston Scientific, you will find purpose, a place to grow and opportunities to cultivate your passions. To search and apply for open positions, visit https://bostonscientific.eightfold.ai/careers. You may also review our social media guidelines at http://www.bostonscientific.com/social.
A global leader in advanced diagnostics, Beckman Coulter has challenged convention to elevate the diagnostic laboratory’s role in improving patient health for more than 80 years. Our mission is to Relentlessly Reimagine Healthcare, One Diagnosis at a Time – and we do this by applying the power of science, technology and the passion and creativity of our teams. Our diagnostic solutions are used in complex clinical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. We exist to deliver smarter, faster diagnostic solutions that move the needle forward from what’s now to what’s next. We do this by accelerating care with an extensive clinical menu, scalable lab automation technologies, insightful clinical informatics, and optimize lab performance services. Headquartered in Brea, Calif., Beckman Coulter Diagnostics has more than 11,000 global team members. Beckman Coulter is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health.
For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside clinicians and providers around the world. We believe every person — regardless of who they are or where they are from — deserves a chance to live a healthy life, free from illness and full of possibility. At the intersection of progress and purpose is where we are redefining what it means to be a global medtech leader. It is where we are relentlessly pursuing healthcare transformation, fueled by our compassion for patients and providers and the challenges they face. It is where bold ideas meet the promise for meaningful change in the world around us. We are there, at every step of the journey, to help clinicians deliver the best care possible.
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at stryker.com and careers.stryker.com. Facts: ● 2024 Sales: $22.6 billion ● Industry: Medical Instruments & Supplies ● Employees: 53,000 worldwide ● 40 years of sales growth leading up to 2020 ● 44+ Manufacturing and R&D Locations Worldwide ● $1.5 billion spent on research and development in 2024 ● ~14,200 patents owned globally in 2024 ● Products sold in ~75 countries ● Fortune 500 Company ● 7 consecutive years as one of Fortune's World's Best Workplaces Stryker’s social media community guidelines: https://www.stryker.com/content/m/legal/social-media-community-guidelines/en/index.html Notice Regarding Employee Conduct on Facebook/LinkedIn Meta/LinkedIn does not permit employers to verify or validate “employees” in the (META: “Works at” LinkedIn: “Experience”) section of users’ profiles. Please be aware that the views expressed by individuals on their personal accounts and do not necessarily represent the views of our company. If you encounter any issues with a person claiming to be our employee, we recommend using the “Report Profile” feature. If you’d like to report concerns to our Ethics Hotline, you may do so at: https://app.convercent.com/en-us/LandingPage/b6bb4e84-9fcb-ea11-a974-000d3ab9f296
Latest updates, reports, and threat intel affecting the global network.
A federal civil rights office inside HHS has shifted its focus from investigating cybersecurity breaches and protecting patient privacy to enforcing bans.
The London-headquartered law firm's entire local cybersecurity practice is leaving, taking to one-third the number of senior departures over...
National law firm Thomson Geer has moved to bolster its IP and technology offerings with the appointment of a team of nine, including two partners, to its...
We should pay attention to lessons learned in cybersecurity before adopting digital watermarks in pursuit of GenAI safety.
Dan Geer has a long history. Milestones: The X Window System and Kerberos (1988), the first information security consulting firm on Wall Street.
Women in science, technology, engineering, and mathematics (STEM) fields have long been overlooked in the celebration of discoveries and...
Cyber war has become an emerged aspect of broader armed conflicts, commencing before the first shot is fired, cybersecurity expert Kenneth Geers told the...
After years of attacks on Ukraine, Russia's invasion has been surprisingly limited in one domain: cyber-warfare.
The Putin-Lipov meeting shows that Russia is not backing down from its quest for control of the internet, threatening the global open...
FileBrowser Quantum is a free, self-hosted, web-based file manager. Versions prior to 1.3.2-stable, 1.4.0-beta and 1.4.1-beta are vulnerable to Path Traversal through the publicPatchHandler in backend/http/public.go which joins user-controlled fromPath and toPath body fields with the trusted d.share.Path BEFORE the downstream sanitizer runs. Because filepath.Join collapses .. segments during the join, the sanitizer in resourcePatchHandler never sees the traversal and the move/copy/rename operates on a path outside the shared directory. The same root-cause pattern was patched for the bulk DELETE endpoint as CVE-2026-44542 (GHSA-fwj3-42wh-8673), but the PATCH handler with the identical pattern was not updated. A public share link with AllowModify=true is sufficient to exploit this. Anyone holding such a link can move, copy, or rename arbitrary files within the share owner's source root. This issue has been fixed in versions 1.3.3-stable and 1.4.2-beta.
stable-diffusion.cpp is a pure C/C++ library for running diffusion model (Stable Diffusion, Flux, Wan, Qwen Image, Z-Image, and more) inference. In versions prior to master-584-0a7ae07, the pickle .ckpt parser in src/model.cpp contained a heap buffer overflow vulnerability in the GLOBAL opcode handler. The issue was caused by missing validation when searching for newline-delimited fields. A crafted .ckpt file without the expected newline could cause the parser to use -1 as a copy length, resulting in immediate heap corruption. The attack requires the victim or application to load a .ckpt file from an untrusted source, such as a downloaded model from a model sharing site. The issue has been resolved in version master-584-0a7ae07. If developers are unable to immediately update their applications they can work around this issue by following these instructions: do not load .ckpt checkpoint files from untrusted sources, and prefer trusted model sources and safer formats such as .safetensors where possible.
stable-diffusion.cpp is a pure C/C++ library for running diffusion model (Stable Diffusion, Flux, Wan, Qwen Image, Z-Image, and more) inference. In versions prior to master-584-0a7ae07, the pickle .ckpt parser in src/model.cpp contained a heap buffer overflow vulnerability in the BINUNICODE opcode handler. The issue was caused by sign confusion on the opcode length field. A crafted .ckpt file could trigger memcpy with a very large length derived from a negative signed value, causing immediate heap corruption. The issue has been resolved in version master-584-0a7ae07. If developers are unable to immediately update their applications they can work around this issue by only loading .ckpt checkpoint files from trusted sources and preferring trusted model sources and safer formats such as .safetensors where possible.
In OpenStack Nova before 33.0.2, the server create API does not strip certain hint data. The resulting instance has no Placement allocation.
The device has a webserver that exposes a REST API authenticated with a token on the management network. By exploiting an OS command injection vulnerability an authenticated attacker can send arbitrary commands to the device that are executed with administrative permissions by the underlying operating system.
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.